These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 4633958)

  • 21. Vaccines produced in diploid cell lines.
    Ikić D
    Natl Cancer Inst Monogr; 1968 Dec; 29():485-93. PubMed ID: 4976866
    [No Abstract]   [Full Text] [Related]  

  • 22. Application of measurement and control of dissolved oxygen pressure to vaccine production.
    Van Hemert P
    Biotechnol Bioeng Symp; 1974; 0(4-2):741-53. PubMed ID: 4369790
    [No Abstract]   [Full Text] [Related]  

  • 23. [The morphology of cell lines suitable for vaccine production studied by scanning electron microscopy].
    Karmysheva VIa; Rovenskiĭ IuA; Mironova OI; Koniushko OI; Khapchaev IuKh
    Tsitologiia; 1992; 34(1):84-8. PubMed ID: 1636216
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Type 4 adenovirus vaccine, live, prepared in human diploid cell system for oral administration.
    Tint H; Stone JL; Minecci LC; Rubin BA
    Prog Immunobiol Stand; 1967; 3():113-22. PubMed ID: 5379935
    [No Abstract]   [Full Text] [Related]  

  • 25. Monkey cell cultures in virology.
    Sohier R; Gaudin OG
    Primates Med; 1969; 3(0):80-92. PubMed ID: 4366899
    [No Abstract]   [Full Text] [Related]  

  • 26. [Kinetics of incorporation of thymidine-H3 in cell cultures infected with rubella virus].
    Gerna G; Favino A; Franchi P
    Boll Soc Ital Biol Sper; 1973 Apr; 49(7):362-7. PubMed ID: 4206449
    [No Abstract]   [Full Text] [Related]  

  • 27. Enhancement of rubella virus replication in swine testicle cells by co-infection with hog cholera virus.
    Soda K; Matumoto M
    Jpn J Microbiol; 1971 Sep; 15(5):397-406. PubMed ID: 5003257
    [No Abstract]   [Full Text] [Related]  

  • 28. Suggested methods for the management and testing of a passaged diploid cell culture used for virus vaccine production.
    Perkins FT
    Jpn J Med Sci Biol; 1971 Oct; 24(5):342-4. PubMed ID: 5316784
    [No Abstract]   [Full Text] [Related]  

  • 29. Identification standards of primary cultures and diploid cell lines--discussion.
    Stulberg CS
    Natl Cancer Inst Monogr; 1968 Dec; 29():15-9. PubMed ID: 5720789
    [No Abstract]   [Full Text] [Related]  

  • 30. Vaccines produced in heteroploid cell lines--discussion.
    Hull RN
    Natl Cancer Inst Monogr; 1968 Dec; 29():471-2. PubMed ID: 4976366
    [No Abstract]   [Full Text] [Related]  

  • 31. On diploid cell lines.
    Hsu TC; Cooper JE
    J Natl Cancer Inst; 1974 Nov; 53(5):1431-6. PubMed ID: 4214940
    [No Abstract]   [Full Text] [Related]  

  • 32. [Cell-containing substrates and vaccine production].
    Majer M
    Schweiz Med Wochenschr; 1970 Nov; 100(48):2086-9. PubMed ID: 5003834
    [No Abstract]   [Full Text] [Related]  

  • 33. The need for a standardised cell substrate for virus vaccine production.
    Perkins FT
    Ann Ist Super Sanita; 1969; 5(1):82-9. PubMed ID: 5382315
    [No Abstract]   [Full Text] [Related]  

  • 34. Vaccine production in human diploid cell strains.
    Plotkin SA
    Am J Epidemiol; 1971 Oct; 94(4):303-6. PubMed ID: 4329326
    [No Abstract]   [Full Text] [Related]  

  • 35. Serially-propagated human diploid cells: a synopsis of the present position concerning their use or producing viral vaccines and interferon.
    Jacobs JP
    Dev Biol Stand; 1979; 42():13-8. PubMed ID: 467795
    [TBL] [Abstract][Full Text] [Related]  

  • 36. General discussion the papers of session 3. Developments with viral vaccines.
    Prog Immunobiol Stand; 1971; 5():213-4. PubMed ID: 4349822
    [No Abstract]   [Full Text] [Related]  

  • 37. A COMPARISON OF PRIMARY MONKEY KIDNEY, HETEROPLOID CELL LINES, AND HUMAN DIPLOID CELL STRAINS FOR HUMAN VIRUS VACCINE PREPARATION.
    HAYFLICK L
    Am Rev Respir Dis; 1963 Sep; 88():SUPPL 387-93. PubMed ID: 14064953
    [No Abstract]   [Full Text] [Related]  

  • 38. Live, attenuated rubella-virus vaccine.
    Hilleman MR; Buynak EB; Weibel RE; Stokes J
    N Engl J Med; 1968 Aug; 279(6):300-3. PubMed ID: 4969117
    [No Abstract]   [Full Text] [Related]  

  • 39. A perfusion culture system for virus vaccine manufacture in diploid cell cultures.
    Mann GF; de Mucha Macías J
    Bull Pan Am Health Organ; 1976; 10(3):205-11. PubMed ID: 187274
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characteristics of an attenuated rubella virus strain (Cendehill).
    Huygelen C; Peetermans J
    Prog Immunobiol Stand; 1967; 3():181-7. PubMed ID: 4985508
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.